Skip to main content
OpenTrials

Clinical trial condition

Non-Small-Cell Lung Carcinoma

Explore clinical trials studying Non-Small-Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

61 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Non-Small-Cell Lung Carcinoma trial results

Completed

Study to Evaluate Erlotinib With or Without SNDX-275 (Entinostat) in the Treatment of Patients With Advanced NSCLC

NCT00602030

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • HOPE (Hematology Oncology Physicians & Extenders) Tucson, Arizona, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Advanced Medical Specialties Miami, Florida, United States
  • Ocala Oncology Center Ocala, Florida, United States
View all 30 locations
View Trial Details
Completed

Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-up

NCT00198341

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Centre Hospitalier - Pneumologie Belfort, France
  • CHU Besancon - Pneumologie Besançon, France
  • Centre F. Baclesse Caen, France
  • CHU - Pneumologie Caen, France
View Trial Details
Completed

Study of Nivolumab for Advanced Cancers in India

NCT03444766

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +22 more
Locations
  • Local Institution Bangalore, India
  • Local Institution Bangalore, India
  • Local Institution Bengaluru, India
  • Local Institution Hyderabad, India
View Trial Details
Completed

Trial of Image-Guided Adaptive Conformal Photon vs Proton Therapy, With Concurrent Chemotherapy, for Locally Advanced Non-Small Cell Lung Carcinoma: Treatment Related Pneumonitis and Locoregional Recurrence

NCT00915005

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Frequency of EGFR Mutations in Latinos/Hispanics With Non-Small Cell Lung Cancer

NCT01255150

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Denver Health Medical Center Denver, Colorado, United States
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
  • Kettering Health Network Kettering, Ohio, United States
  • Oregon Health and Sciences Universtiy Cancer Center Portland, Oregon, United States
View Trial Details
Completed

A Study in Non-Small Cell Lung Cancer

NCT01232452

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chicago, Illinois, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hackensack, New Jersey, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Portland, Oregon, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Memphis, Tennessee, United States
View all 44 locations
View Trial Details
Completed

A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment

NCT01801111

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • St. Jude Heritage Healthcare Fullerton, California, United States
  • UC Irvine Medical Center Orange, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
View all 84 locations
View Trial Details

Related conditions